Brind.

Partnership between Dexcom, Amazon, and Oura regarding FDA clearance for a 15-day G7 sensor.

1 report, 1 independent Updated Aug 20

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Dexcom Amazon FDA

Keep exploring

The entities involved

Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18
- Oura announces partnerships with Dexcom and Resmed for health feature integration, while noting that regulatory uncertainty affects its product scope.Wed 08:52
Amazon
American multinational technology company
- Nvidia is expanding its platform deployment across major cloud providers, including Google Cloud and Microsoft Azure.Mon 17:31
- Arianespace, a subsidiary of ArianeGroup, launched satellites for Amazon Leo constellation, supporting ESA's access to space.Mon 17:10
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Aug 20ZacksDexCom Expands Access and Innovation While Balancing Headwinds DexCom, Inc. DXCM reported second-quarter 2025 results that highlighted robust top-line growth, continued progress in expanding access a